Federated Hermes, Inc. Genetron Holdings LTD Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$13.71 - $30.64 $548,400 - $1.23 Million	-40,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.31 - $14.0 $186,200 - $280,000	-20,000 Reduced 33.33%	40,000 $560,000
Q3 2020 Nov 12, 2020	BUY	$9.1 - $15.81 $91,000 - $158,100	10,000 Added 20.0%	60,000 $717,000
Q2 2020 Aug 13, 2020	BUY	$11.29 - $16.0 $564,500 - $800,000	50,000 New	50,000 $603,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.